SEC Form D private-offering filing

Cresilon, Inc.

Name: Cresilon, Inc. - new SEC Form D private-offering filing, Brooklyn, NY
Published: 2025-12-08

A new SEC Form D private-offering notice from Brooklyn, NY, a $6,716,808 filer-stated offering target in Biotech. The source filing is one click away.

Cresilon, Inc. site↗ Verified via SEC Form D

Develops and manufactures plant based hemostatic gel technology for controlling traumatic and surgical bleeding, including the TRAUMAGEL and VETIGEL product lines.

Filed 2025-12-08Filed to raise $6,716,808First money in 2025-11-21Raised so far $6,683,401HQ (as filed) Brooklyn, NYSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified cresilon.com↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.